Jimi Eijiro, Hirata Shizu, Osawa Kenji, Terashita Masamichi, Kitamura Chiaki, Fukushima Hidefumi
Division of Molecular Signaling and Biochemistry, Department of Biosciences, Kyushu Dental College, 2-6-1 Manazuru, Kokurakita-ku, Kitakyushu, Fukuoka 803-8580, Japan.
Int J Dent. 2012;2012:148261. doi: 10.1155/2012/148261. Epub 2012 Mar 13.
Bone defects often result from tumor resection, congenital malformation, trauma, fractures, surgery, or periodontitis in dentistry. Although dental implants serve as an effective treatment to recover mouth function from tooth defects, many patients do not have the adequate bone volume to build an implant. The gold standard for the reconstruction of large bone defects is the use of autogenous bone grafts. While autogenous bone graft is the most effective clinical method, surgical stress to the part of the bone being extracted and the quantity of extractable bone limit this method. Recently mesenchymal stem cell-based therapies have the potential to provide an effective treatment of osseous defects. In this paper, we discuss both the current therapy for bone regeneration and the perspectives in the field of stem cell-based regenerative medicine, addressing the sources of stem cells and growth factors used to induce bone regeneration effectively and reproducibly.
骨缺损通常由肿瘤切除、先天性畸形、创伤、骨折、手术或牙科中的牙周炎引起。尽管牙种植体是从牙齿缺损恢复口腔功能的有效治疗方法,但许多患者没有足够的骨量来植入种植体。重建大骨缺损的金标准是使用自体骨移植。虽然自体骨移植是最有效的临床方法,但取自体骨部位的手术应激以及可提取骨的数量限制了这种方法。最近,基于间充质干细胞的疗法有可能为骨缺损提供有效的治疗。在本文中,我们讨论了当前的骨再生治疗方法以及基于干细胞的再生医学领域的前景,探讨了用于有效且可重复诱导骨再生的干细胞和生长因子的来源。